HK Stock Market Move | ZHAOKE OPHTH-B (06622) has increased by over 10% again. The company has obtained the medical device registration certificate for TONO-i, used for measuring eye pressure, from the National Medical Products Administration.

ZHAOKE OPHTH-B (06622) rose by over 10%, reaching a 9.32% increase to 3.4 Hong Kong dollars as of the time of this report, with a trading volume of 11.3254 million Hong Kong dollars. On the news front, ZHAOKE Ophthalmology announced that the company has obtained the medical device registration certificate for TONO-i from the National Medical Products Administration. TONO-i will be an important part of the company's portfolio of glaucoma medical products, meeting the demand gap for low diagnosis and treatment rates in China. TONO-i provides ophthalmologists with a tool to easily, accurately, and comprehensively monitor patients' eye pressure, helping to provide immediate and continuous feedback on the effectiveness of treatment, and improving patient compliance with glaucoma drug therapy. It is worth noting that in November 2022, the company reached an exclusive distribution agreement with C&VTech regarding TONO-i. C&VTech is a leading company in the field of developing medical devices for the diagnosis, treatment, and prevention of glaucoma. According to the terms of the agreement, the company has exclusive rights to register, import, promote, distribute, market, and sell TONO-i in Greater China. These rights were later expanded through contract revisions to include Thailand and Malaysia, effective from August 2024.